Plant-Based Nutrition for Breast or Endometrial Cancer

NCT ID: NCT07189702

Last Updated: 2025-09-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-31

Study Completion Date

2029-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized controlled trial of a whole food, plant-based (WFPB) dietary intervention among women with metastatic breast or endometrial cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a randomized controlled trial of a whole food, plant-based (WFPB) dietary intervention among women with metastatic breast or endometrial cancer. It is designed to explore whether this dietary intervention is sustainable in this population for 26 weeks and whether improvements in quality of life and cardiometabolic health demonstrated in a previous study are sustained. If so, this study will gather information to know whether these benefits translate into reduced overall mortality and cancer markers when compared with a control group that is matched for time and attention but does not implement dietary change. The intervention consists of a whole food plant-based dietary program, group education and individual coaching/visits while the control group gets general wellness group education and individual visits while maintaining their usual diet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Metastatic Endometrial Cancer Stage IV

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Regular Diet with Cancer-Related Wellness Education and Support

Group Type ACTIVE_COMPARATOR

Control

Intervention Type OTHER

Regular Diet with Cancer-Related Wellness Education and Support

Whole Food, Plant-Based Diet with Behavioral Education and Support

Whole Food, Plant-Based Diet with Behavioral Education and Support

Group Type EXPERIMENTAL

Whole Food, Plant-Based Diet with Behavioral Education and Support

Intervention Type OTHER

Whole Food, Plant-Based Diet with Behavioral Education and Support

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control

Regular Diet with Cancer-Related Wellness Education and Support

Intervention Type OTHER

Whole Food, Plant-Based Diet with Behavioral Education and Support

Whole Food, Plant-Based Diet with Behavioral Education and Support

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A confirmed diagnosis of endometrial or metastatic breast cancer. All subtypes are eligible
* Treating oncologist approval and expected survival of at least six months
* Undergoing any systemic treatment including hormonal, cytotoxic, targeted monoclonal antibody or small molecule kinase inhibitors or any combination of the above. Women who have active cancer and have been recommended but declined systemic treatment are also eligible.
* Willing to adopt a strict, whole-foods, plant-based diet
* Willing and able to comply with the WFPB protocol for the duration of the study including scheduled testing, Zoom meetings, and office visits
* Able to speak and read English fluently.
* Women with plans for radiation therapy or surgery are also eligible provided that they meet all other eligibility criteria.

Exclusion Criteria

* Inability to tolerate a normal diet
* Active malabsorption syndrome at time of consent, as determined by study physicians (i.e. Crohn's disease, bowel surgery)
* Any food allergies or intolerances that would interfere with study compliance
* Recent consumption (in the past six months) of a vegan diet
* eGFR \< 30 on ≥ two lab tests in the past six months
* Serum potassium \> 5.4 in the past six months
* Current insulin or sulfonylurea use
* Current warfarin use (non-vitamin K antagonist allowed)
* High-risk alcohol use (\>7 drinks/wk)
* Illicit substance use (not including marijuana)
* Cognitive impairment or psychiatric disorder impairing ability to give consent.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Rochester

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thomas M Campbell

Assistant Professor (Part-Time) - Department of Family Medicine (SMD)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas M Campbell, MD

Role: PRINCIPAL_INVESTIGATOR

University of Rochester

Erin K Campbell, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

University of Rochester

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lisa M Blanchard, BS

Role: CONTACT

585-953-6709

Erin k Campbell, MD,MPH

Role: CONTACT

585-602-0477

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00010949

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rx for Better Breast Health
NCT02279303 COMPLETED NA